Literature and new experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing furosemide are reviewed. The available data on solubility, oral absorption, and permeability are suffic
New oral solid dosage form for furosemide oral administration
✍ Scribed by Luana Perioli; Giuseppina D’Alba; Cinzia Pagano
- Book ID
- 116438579
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- French
- Weight
- 736 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0939-6411
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Fast drug release from solid dosage forms requires a very fast contact of the vast majority of the drug particles with the solvent; this, however, is particularly delayed in tablets and granulations. Starch and cellulose substances favor the matrix disintegration during the starting phase and the ge
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage forms containing rifampicin as the only Active Pharmaceutical Ingredient (API) are reviewed. Rifampicin's so